Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.

Salvadori N, Fan B, Teeyasoontranon W, Ngo-Giang-Huong N, Phanomcheong S, Luvira A, Puangsombat A, Suwannarat A, Srirompotong U, Putiyanun C, Cressey TR, Decker L, Khamduang W, Harrison L, Tierney C, Shepherd JA, Kourtis AP, Bulterys M, Siberry GK, Jourdain G.

Clin Infect Dis. 2019 Jun 18;69(1):144-146. doi: 10.1093/cid/ciy982.

PMID:
30924492
2.

Optimising HIV antiretrovirals for mothers and infants.

Powis KM, Siberry GK.

Lancet HIV. 2019 May;6(5):e272-e273. doi: 10.1016/S2352-3018(19)30045-1. Epub 2019 Feb 24. No abstract available.

PMID:
30814029
3.

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus.

Cressey TR, Harrison L, Achalapong J, Kanjanavikai P, Patamasingh Na Ayudhaya O, Liampongsabuddhi P, Siriwachirachai T, Putiyanun C, Suriyachai P, Tierney C, Salvadori N, Chinwong D, Decker L, Tawon Y, Murphy TV, Ngo-Giang-Huong N, Siberry GK, Jourdain G; iTAP Study Team.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01686-18. doi: 10.1128/AAC.01686-18. Print 2018 Dec.

4.

Advancing HIV Biomedical Prevention Research for At-Risk Adolescents.

Kapogiannis BG, Nelson RM, Siberry GK, Lee S, Hazra R.

J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):535-542. doi: 10.1097/QAI.0000000000001853.

PMID:
30204722
5.

Ensuring Children and Adolescents Are Not Left Behind.

Bekker LG, Siberry GK, Hirnschall G.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1:S1-S2. doi: 10.1097/QAI.0000000000001751. No abstract available.

6.

Strategies for Identifying and Linking HIV-Infected Infants, Children, and Adolescents to HIV Treatment Services in Resource Limited Settings.

Medley AM, Hrapcak S, Golin RA, Dziuban EJ, Watts H, Siberry GK, Rivadeneira ED, Behel S.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S98-S106. doi: 10.1097/QAI.0000000000001732.

PMID:
29994831
7.

Supplement Introduction: Accelerating Children's HIV/AIDS Treatment (ACT) Initiative: Using What We Learned to Maintain the Pace to Close the Pediatric HIV Treatment Gap.

Siberry GK, Amzel A, Watts DH, Ahmed S.

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S63-S64. doi: 10.1097/QAI.0000000000001728. No abstract available.

PMID:
29994826
8.

Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.

Penazzato M, Watkins M, Morin S, Lewis L, Pascual F, Vicari M, Lee J, Hargreaves S, Doherty M, Siberry GK.

Lancet HIV. 2018 May;5(5):e259-e264. doi: 10.1016/S2352-3018(18)30005-5. Epub 2018 May 1.

PMID:
29739700
9.

A pragmatic approach to monitor and evaluate implementation and impact of differentiated ART delivery for global and national stakeholders.

Ehrenkranz PD, Calleja JM, El-Sadr W, Fakoya AO, Ford N, Grimsrud A, Harris KL, Jed SL, Low-Beer D, Patel SV, Rabkin M, Reidy WJ, Reinisch A, Siberry GK, Tally LA, Zulu I, Zaidi I.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25080.

10.

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N.

N Engl J Med. 2018 Mar 8;378(10):911-923. doi: 10.1056/NEJMoa1708131.

11.

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.

Buchholz UJ, Cunningham CK, Muresan P, Gnanashanmugam D, Sato P, Siberry GK, Rexroad V, Valentine M, Perlowski C, Schappell E, Thumar B, Luongo C, Barr E, Aziz M, Yogev R, Spector SA, Collins PL, McFarland EJ, Karron RA; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1114 Study Team.

J Infect Dis. 2018 Apr 11;217(9):1338-1346. doi: 10.1093/infdis/jiy066.

12.

Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children.

McFarland EJ, Karron RA, Muresan P, Cunningham CK, Valentine ME, Perlowski C, Thumar B, Gnanashanmugam D, Siberry GK, Schappell E, Barr E, Rexroad V, Yogev R, Spector SA, Aziz M, Patel N, Cielo M, Luongo C, Collins PL, Buchholz UJ; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) 2000 Study Team.

J Infect Dis. 2018 Apr 11;217(9):1347-1355. doi: 10.1093/infdis/jiy040.

13.

Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries.

Penazzato M, Lewis L, Watkins M, Prabhu V, Pascual F, Auton M, Kreft W, Morin S, Vicari M, Lee J, Jamieson D, Siberry GK.

J Int AIDS Soc. 2018 Feb;21 Suppl 1. doi: 10.1002/jia2.25049.

14.

Risk for Speech and Language Impairments in Preschool Age HIV-exposed Uninfected Children With In Utero Combination Antiretroviral Exposure.

Rice ML, Russell JS, Frederick T, Purswani M, Williams PL, Siberry GK, Redmond SM, Hoffman HJ, Yao TJ; Pediatric HIV/AIDS Cohort Study (PHACS).

Pediatr Infect Dis J. 2018 Jul;37(7):678-685. doi: 10.1097/INF.0000000000001875.

15.

Beyond Prevention of Vertical HIV Transmission - Improving Outcomes of HIV-Uninfected Infants Born to Mothers with HIV Infection.

Siberry GK.

Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001854. [Epub ahead of print] No abstract available.

PMID:
29200183
16.

Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America.

Succi RCM, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Pavia Ruz N, Pierre RB, Kolevic Roca LA, Joao E, Foradori I, Scotta MC, Hazra R, Siberry GK; NISDI Pediatric Study Group 2012.

Pediatr Infect Dis J. 2018 Apr;37(4):304-309. doi: 10.1097/INF.0000000000001831.

17.

In Search of the Right Time and Right Place: Screening Adolescents and Youth for Human Immunodeficiency Virus in the United States.

Rakhmanina N, Siberry GK.

J Adolesc Health. 2018 Jan;62(1):3-4. doi: 10.1016/j.jadohealth.2017.09.003. Epub 2017 Nov 10. No abstract available.

PMID:
29133023
18.

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines.

Pinto JA, Capparelli EV, Warshaw M, Zimmer B, Cressey TR, Spector SA, Qin M, Smith B, Siberry GK, Mirochnick M; IMPAACT P1083 Team.

Pediatr Infect Dis J. 2018 Feb;37(2):e29-e35. doi: 10.1097/INF.0000000000001817.

19.

Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.

Siberry GK, Amzel A, Ramos A, Rivadeneira ED.

J Infect Dis. 2017 Dec 1;216(suppl_9):S838-S842. doi: 10.1093/infdis/jix407.

20.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.

Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM.

JAMA Pediatr. 2017 Nov 1;171(11):1063-1071. doi: 10.1001/jamapediatrics.2017.2007.

21.

Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial.

Agwu AL, Warshaw MG, McFarland EJ, Siberry GK, Melvin AJ, Wiznia AA, Fairlie L, Boyd S, Harding P, Spiegel HML, Abrams EJ, Carey VJ; P1094 Study Team.

PLoS One. 2017 Jun 12;12(6):e0178075. doi: 10.1371/journal.pone.0178075. eCollection 2017.

22.

Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and Youth.

Warshaw MG, Siberry GK, Williams P, Decker MD, Jean-Philippe P, Lujan-Zilbermann J.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e69-e74. doi: 10.1093/jpids/piw094.

23.

Building Sustainable Local Capacity for Global Health Research in West Africa.

Sam-Agudu NA, Paintsil E, Aliyu MH, Kwara A, Ogunsola F, Afrane YA, Onoka C, Awandare GA, Amponsah G, Cornelius LJ, Mendy G, Sturke R, Ghansah A, Siberry GK, Ezeanolue EE.

Ann Glob Health. 2016 Nov - Dec;82(6):1010-1025. doi: 10.1016/j.aogh.2016.10.011.

PMID:
28314488
24.

Long-term pulmonary complications in perinatally HIV-infected youth.

Shearer WT, Jacobson DL, Yu W, Siberry GK, Purswani M, Siminski S, Butler L, Leister E, Scott G, Van Dyke RB, Yogev R, Paul ME, Puga A, Colin AA, Kattan M; Pediatric HIV/AIDS Cohort Study.

J Allergy Clin Immunol. 2017 Oct;140(4):1101-1111.e7. doi: 10.1016/j.jaci.2017.01.031. Epub 2017 Mar 6.

25.

Lymphocyte subsets in HIV-exposed uninfected infants and HIV-unexposed uninfected infants.

Huo Y, Patel K, Scott GB, Van Dyke RB, Siberry GK, Burchett SK, Shearer WT.

J Allergy Clin Immunol. 2017 Aug;140(2):605-608.e3. doi: 10.1016/j.jaci.2017.01.033. Epub 2017 Mar 6. No abstract available.

26.

Prevalence and Associated Characteristics of HIV-Infected Children in Latin America Who Know Their HIV Status.

Lee S, Siberry GK, Alarcón JO, Vega MR, Roca LK, Gutierrez C, Celia de Menezes Succi R, Ferreira Peixoto M, Stoszek SK, Hazra R, Harris DR.

J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):78-81. doi: 10.1093/jpids/pix001.

27.

Longitudinal Evaluation of Language Impairment in Youth With Perinatally Acquired Human Immunodeficiency Virus (HIV) and Youth With Perinatal HIV Exposure.

Redmond SM, Yao TJ, Russell JS, Rice ML, Hoffman HJ, Siberry GK, Frederick T, Purswani M, Williams PL; Pediatric HIV/AIDS Cohort Study.

J Pediatric Infect Dis Soc. 2016 Dec;5(suppl 1):S33-S40.

28.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

29.

Growth at 2 Years of Age in HIV-exposed Uninfected Children in the United States by Trimester of Maternal Antiretroviral Initiation.

Jacobson DL, Patel K, Williams PL, Geffner ME, Siberry GK, DiMeglio LA, Crain MJ, Mirza A, Chen JS, McFarland E, Kacanek D, Silio M, Rich K, Borkowsky W, Van Dyke RB, Miller TL; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2017 Feb;36(2):189-197. doi: 10.1097/INF.0000000000001387.

30.

Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Melvin AJ, Montepiedra G, Aaron L, Meyer WA 3rd, Spiegel HM, Borkowsky W, Abzug MJ, Best BM, Crain MJ, Borum PR, Graham B, Anthony P, Shin K, Siberry GK; P1063 Study Team.

Pediatr Infect Dis J. 2017 Jan;36(1):53-60.

31.

Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth.

Jao J, Freimanis L, Mussi-Pinhata MM, Cohen RA, Monteiro JP, Cruz ML, Branch A, Sperling RS, Siberry GK; NISDI LILAC Protocol.

Am J Perinatol. 2017 Apr;34(5):486-492. doi: 10.1055/s-0036-1593536. Epub 2016 Oct 7.

32.

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.

Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N.

BMC Infect Dis. 2016 Aug 9;16:393. doi: 10.1186/s12879-016-1734-5.

33.

Concept Mapping of PMTCT Implementation Challenges and Solutions Across 6 sub-Saharan African Countries in the NIH-PEPFAR PMTCT Implementation Science Alliance.

Aarons GA, Sommerfeld DH, Chi BH, Ezeanolue EE, Sturke R, Guay L, Siberry GK.

J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S202-6. doi: 10.1097/QAI.0000000000001064.

PMID:
27355510
34.

Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.

Price JT, Wheeler SB, Stranix-Chibanda L, Hosek SG, Watts DH, Siberry GK, Spiegel HM, Stringer JS, Chi BH.

J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S145-53. doi: 10.1097/QAI.0000000000001063.

35.

Phenotypic Coreceptor Tropism in Perinatally HIV-infected Youth Failing Antiretroviral Therapy.

Agwu AL, Yao TJ, Eshleman SH, Patel K, Huang W, Burchett SK, Siberry GK, Van Dyke RB; Pediatric HIVAIDS Cohort Study.

Pediatr Infect Dis J. 2016 Jul;35(7):777-81. doi: 10.1097/INF.0000000000001158.

36.

Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.

Kapogiannis BG, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, Williams PL; REACH Study and the PACTG 219219C Study.

AIDS. 2016 Mar 27;30(6):889-98. doi: 10.1097/QAD.0000000000001003.

37.

Reply to Koo et al.

Siberry GK, Jacobson DL; for coauthors and the Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2016 May 15;62(10):1324-5. doi: 10.1093/cid/ciw116. Epub 2016 Mar 1. No abstract available.

38.

Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.

Spaulding AB, Yu Q, Civitello L, Mussi-Pinhata MM, Pinto J, Gomes IM, Alarcón JO, Siberry GK, Harris DR, Hazra R.

AIDS Res Hum Retroviruses. 2016 Apr;32(4):349-56. doi: 10.1089/AID.2015.0254.

39.

Meningococcal Conjugate and Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccination Among HIV-infected Youth.

Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL; LEGACY Consortium.

Pediatr Infect Dis J. 2016 May;35(5):e152-7. doi: 10.1097/INF.0000000000001078.

PMID:
26855409
40.

Newborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected Infants.

Torre P Rd, Zeldow B, Yao TJ, Hoffman HJ, Siberry GK, Purswani MU, Frederick T, Spector SA, Williams PL.

J AIDS Immune Res. 2016;1(1). pii: 102. Epub 2016 Sep 5.

41.

Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches.

Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, Markby J.

J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015. Review.

42.

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Purswani MU, Karalius B, Yao TJ, Schmid DS, Burchett SK, Siberry GK, Patel K, Van Dyke RB, Yogev R; Pediatric HIV/AIDS Cohort Study (PHACS), Lurie RH, Yogev R, Sanders MA, Malee K, Hunter S, Shearer W, Paul M, Cooper N, Harris L, Purswani M, Baig M, Cintron A, Puga A, Navarro S, Garvie P, Blood J, Burchett S, Karthas N, Kammerer B, Wiznia A, Burey M, Nozyce M, Dieudonne A, Bettica L, Adubato S, Chen J, Bulkley MG, Ivey L, Grant M, Knapp K, Allison K, Wilkins M, Acevedo-Flores M, Rios H, Olivera V, Silio M, Jones M, Sirois P, Spector S, Norris K, Nichols S, McFarland E, Katai A, Dunn J, Paul S, Scott G, Bryan P, Willen E.

Clin Infect Dis. 2016 Jan 1;62(1):106-114. doi: 10.1093/cid/civ734. Epub 2015 Sep 18.

43.

Repeat pregnancy in women with HIV infection in Latin America and the Caribbean.

Kreitchmann R, Megazzini K, Melo VH, Fernandes Coelho D, Watts DH, Krauss M, Gouvea MI, Duarte G, Losso MH, Siberry GK.

AIDS Care. 2015;27(10):1289-97. doi: 10.1080/09540121.2015.1050987. Epub 2015 Aug 19.

44.

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.

Fairlie L, Karalius B, Patel K, van Dyke RB, Hazra R, Hernán MA, Siberry GK, Seage GR 3rd, Agwu A, Wiznia A; Pediatric HIV AIDS Cohort Study (PHACS), The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT).

AIDS. 2015 Oct 23;29(16):2109-19. doi: 10.1097/QAD.0000000000000809.

45.

Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.

Siberry GK, Patel K, Bellini WJ, Karalius B, Purswani MU, Burchett SK, Meyer WA 3rd, Sowers SB, Ellis A, Van Dyke RB; Pediatric HIV AIDS Cohort Study (PHACS); Pediatric HIV AIDS Cohort Study PHACS.

Clin Infect Dis. 2015 Sep 15;61(6):988-95. doi: 10.1093/cid/civ440. Epub 2015 Jun 9.

46.

Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.

Siberry GK, Jacobson DL, Kalkwarf HJ, Wu JW, DiMeglio LA, Yogev R, Knapp KM, Wheeler JJ, Butler L, Hazra R, Miller TL, Seage GR 3rd, Van Dyke RB, Barr E, Davtyan M, Mofenson LM, Rich KC; Pediatric HIV/AIDS Cohort Study.

Clin Infect Dis. 2015 Sep 15;61(6):996-1003. doi: 10.1093/cid/civ437. Epub 2015 Jun 9.

47.

National Institutes of Health investment in studies of HIV disclosure to children.

Allison SM, Siberry GK.

AIDS. 2015 Jun;29 Suppl 1:S109-18. doi: 10.1097/QAD.0000000000000663. Review.

PMID:
26049535
48.

Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.

Himes SK, Huo Y, Siberry GK, Williams PL, Rice ML, Sirois PA, Frederick T, Hazra R, Huestis MA; Pediatric HIVAIDS Cohort Study.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):178-86. doi: 10.1097/QAI.0000000000000558.

49.

Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.

Himes SK, Wu JW, Jacobson DL, Tassiopoulos K, Hazra R, Kacanek D, Van Dyke RB, Rich KC, Siberry GK, Huestis MA; Pediatric HIVAIDS Cohort Study (PHACS).

Pediatr Infect Dis J. 2015 Aug;34(8):851-7. doi: 10.1097/INF.0000000000000747.

50.

Long-term postpartum adherence to antiretroviral drugs among women in Latin America.

Kreitchmann R, Coelho DF, Kakehasi FM, Hofer CB, Read JS, Losso M, Haberer JE, Siberry GK, Harris DR, Yu Q.

Int J STD AIDS. 2016 Apr;27(5):377-86. doi: 10.1177/0956462415584483. Epub 2015 Apr 29.

PMID:
25931238

Supplemental Content

Loading ...
Support Center